Rheon Medical Receives FDA Breakthrough Device Designation for the eyeWatch Technology to Treat Refractory Glaucoma.
Clinical trial confirms Abionic’s ability to detect Sepsis earlier.
Emmanuel de Watteville, General Partner @ Blue Ocean Ventures speaks about who's financing our life sciences' start-ups
CyanoGuard raises USD 0.5 million to advance sustainability and efficiency in gold mining.
Rheon Medical raises CHF 5.6 million in Series C financing round.
MIKAJAKI Announces CE Marking for EyeLib™, the World’s First Automated Ophthalmic Diagnostic Platform.
Luciole Medical AG and Hôpital Fondation Adolphe de Rothschild enter research collaboration in brain oxygenation monitoring.
BlueOcean Ventures invests in MIKAJAKI, inventor of the world’s first ophthalmic diagnostic robotic platform.
CyanoGuard raises over CHF 3m and closes seed round led by Wingman Ventures.
Abionic is launching a pivotal clinical study.